CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Pegfilgrastim

Last Updated: March 29, 2004
Result type: Reports
Project Number: S0009
Product Line: Common Drug Review

Generic Name: Pegfilgrastim

Brand Name: Neulasta

Manufacturer: Amgen Canada Inc.

Indications: Neutropenia

Submission Type: New

Project Status: Complete

Date Recommendation Issued: October 27, 2004

Recommendation Type: List with clinical criteria and/or conditions